Konstantinos Xynos
Vermogen: 3 M $ op 31-07-2026
Vermogen: 3 M $ op 31-07-2026
Konstantinos Xynos is Chief Medical Officer at Replimune Group, Inc. since 2022.
Formerly, Dr. Xynos was Vice President & Head-Global Medical Affairs at Deciphera Pharmaceuticals, Inc. from 2019 to 2021.
Education includes an undergraduate degree from the University of Illinois (1991), a doctorate from Aristotle University of Thessaloniki (1997), a doctorate from National & Kapodistrian University of Athens (2012), and an MBA from the University of Strathclyde (2013).
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 10-08-2026 | 224.215 ( 0,29% ) | 3 M $ | 31-07-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| REPLIMUNE GROUP, INC. | Hoofd Techniek/Wetenschap/O&O | 01-12-2022 |
| Bedrijven | Functie | Einde |
|---|---|---|
| DECIPHERA PHARMACEUTICALS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-01-2021 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 6 |
|---|---|
University of Illinois
University of Illinois Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Strathclyde
University of Strathclyde Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aristotle University of Thessaloniki
Aristotle University of Thessaloniki Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National & Kapodistrian University of Athens
National & Kapodistrian University of Athens Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Replimune Group, Inc.
Replimune Group, Inc. BiotechnologyHealth Technology Develops oncolytic immunotherapies | Health Technology |
Deciphera Pharmaceuticals, Inc.
Deciphera Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops novel drug candidates to improve the lives of cancer patients | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau